Hello – Today, we’re inviting you to take a free look at MarketBeat’s proprietary, up-to-the-minute list of 20 stocks that Wall Street’s top-rated analysts hate. These aren’t mild downgrades or lukewarm opinions.
These are true Strong Sell stocks. Some of them may look fine on the surface. A few even have what appear to be solid fundamentals. But when analysts issue a rare Sell rating, it’s usually because something beneath the surface is deeply wrong. Sell-side analysts may not nail every Buy call… but when they raise red flags, they’re almost always worth listening to. If any of these stocks are lurking around in your portfolio, you may seriously want to consider dumping them.
Click here to see the list now. Stay one step ahead, Matthew Paulson
Founder & CEO, MarketBeat
P.S. Access to 20 Stocks to Sell Now is completely free. Don’t miss your chance to review these timely, high-conviction warnings before the market reacts.
This Week's Exclusive Content 5 April Buys With Double-Digit Year-End TargetsWritten by Thomas Hughes. Posted: 3/27/2026. 
Key Points - Tech stocks are well-positioned to rebound, offering value in early 2026.
- Their improving forecasts are contrary to market headwinds, pointing to continued strength this year.
- Catalysts are likely as the Q1 and full-year 2026 reporting season progresses.
- Special Report: Elon Musk's $1 Quadrillion AI IPO
Stock price action in 2026 faces headwinds, but S&P 500 stocks and many others remain on track to finish the year higher. While challenges persist, bullish fundamentals—centred on the labor market, consumer demand and business spending—continue to support the market. Much of corporate investment is focused on technology, especially data centers and AI, but it extends across industries. The stocks on this list share several traits: exposure to technology, improving outlooks and the potential to deliver high double-digit gains by year-end. NVIDIA: Too Cheap to Ignore There are many reasons to consider buying NVIDIA (NASDAQ: NVDA)deep-value opportunity. Value shows up in both the price-to-earnings multiple and improving analyst trends, which together suggest high-double-digit upside as a reasonable baseline. Trading near 21X projected fiscal 2027 earnings, the stock trades roughly 50% below where blue-chip tech names typically trade, despite a robust forward outlook and strong long-term trends. Longer-term forecasts—which have tended to be conservative—imply NVDA would trade at only 6X the 2035 forecast, suggesting 400%–600% upside over the next five to ten years. 
Key catalysts include the upcoming earnings release, which should confirm trend strength and could accelerate momentum. Competition exists, but NVIDIA's first-mover advantage is substantial and it has the capital to act on it. Investors can also expect more acquisition and investment activity in the months ahead. For now, 53 analysts rate the stock a Buy, with a 96% Buy-side bias and a consensus target implying roughly 50% upside. Advanced Micro Devices: Expensive Today, Super Cheap Versus Tomorrow Advanced Micro Devices (NASDAQ: AMD) trades at a premium to current-year earnings, but near-term earnings understate the company's trajectory. AMD is at a critical pivot point, poised to roll out rack-scale solutions for hyperscale AI datacenters that could unleash substantial demand. Its MI450 products deliver superior performance on some tasks—especially inference—while reducing total cost of ownership, making them an attractive choice as adoption ramps. Analysts expect revenue and earnings acceleration, but those forecasts may be conservative; based on demand trends, AMD's revenue growth could reach triple-digit rates within the first few quarters after the MI450 launch. 
Analyst trends are nearly as bullish as those for NVIDIA. Of the 40 analysts tracked by MarketBeat, the consensus rating is a Moderate Buy; coverage is expanding, sentiment is firming, and the Buy-side bias is 75%. The consensus price target implies about 30% upside, while the high-end of the range roughly doubles that. Nebius Group: Building Capacity as Fast as Possible Nebius Group (NASDAQ: NBIS) faces headwinds—most notably a rising debt load—but a growing backlog driven by deals with Meta and Microsoft offsets those concerns. The most likely scenario is that this data-center-focused business, which has close ties to NVIDIA, continues executing its plan and converts backlog into revenue. The backlog is nearly $50 billion, and revenue recognition should accelerate meaningfully as new projects come online. 
Only 13 analysts currently cover NBIS, but the trends are robust. Coverage has more than doubled on a trailing 12-month basis, sentiment is firming, and 11 of the ratings are Buys. The stock is up nearly 200% TTM, the consensus price target implies over 30% upside, and recent targets are clustering near the high end—another ~20% higher. Amprius Technologies: Winners Keep on Winning Amprius Technologies (NYSE: AMPX) is a classic bull-market story driven by emerging technology: validation through contract awards, capacity ramp-ups, rising demand and improving results and guidance. The most likely outcome is continued advancement, with expanding revenue, margins and profitability. 
The technical picture supports the bullish case: the Q4 2025 earnings release sparked a buying wave that drove the stock to long-term highs. After a period of consolidation, the pattern looks like a continuation setup, making higher prices likely if momentum resumes. BigBear AI: Sell-Off Exhausted, Rebound in the Works BigBear AI (NYSE: BBAI) is not out of the woods yet, but its fiscal 2025 report suggested the company's aggressive repositioning is largely complete. The dilutive capital raises appear to be finished, the balance sheet is in better shape, recent acquisitions position the company for growth, and business trends are improving. The likely outcome is accelerating momentum in upcoming releases, which could trigger short-covering and a more pronounced reversal in the share price. 
With short interest near 27%, the stock is vulnerable to a sharp rebound. Analyst coverage is modest but points to more than 50% upside, and institutional activity shows increased accumulation in Q1 2026. | 
No comments:
Post a Comment